🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07827326
Starting soon Observational

Clinical Utility of Needle-Based Confocal Laser Endomicroscopy for Peripheral Pulmonary Lesions

NCT07827326 · tracked via the Priya Life Science China tracker
Sponsor
First Affiliated Hospital of Ningbo University
Phase
Observational
Started
2026-10-01
Last updated
2026-09-18

Condition(s) studied

Peripheral Pulmonary Lesions

Investigational drug(s) / intervention(s)

Confocal Laser Endomicroscopy

Confocal Laser Endomicroscopy: After successful localization of the peripheral pulmonary lesion using radial probe endobronchial ultrasound, a needle-based confocal laser endomicroscopy probe will be advanced through the same guide sheath. Following intravenous administration of 200 mg fluorescein sodium diluted in 8 mL of normal saline, the probe will be placed in gentle contact with the target lesion to acquire real-time microscopic images. A 1.4-mm probe will be used whenever feasible; a 0.8-mm probe may be used when the larger probe cannot pass through the working channel or guide sheath. The probe position may be adjusted to obtain diagnostically meaningful images. Images will be recorded before bronchoscopic tissue sampling and subsequently evaluated using predefined criteria for malignant and benign lesions. The nCLE findings will be compared with the final diagnosis established by histopathology and follow-up when necessary.

Study summary

This prospective, multicenter diagnostic accuracy study will evaluate the clinical utility of needle-based confocal laser endomicroscopy (nCLE) for differentiating malignant from benign peripheral pulmonary lesions (PPLs). A total of 100 participants undergoing bronchoscopic evaluation of PPLs will be enrolled at three hospitals in China.

Following successful lesion localization using radial endobronchial ultrasound, nCLE imaging will be performed after intravenous administration of fluorescein, followed by standard bronchoscopic tissue sampling. nCLE findings will be compared with the final diagnosis established by histopathology, surgical pathology, or six-month clinical and imaging follow-up when necessary.

The primary outcomes are the sensitivity, specificity, positive predictive value, negative predictive value, and overall diagnostic accuracy of nCLE. Procedure duration and procedure-related adverse events will also be recorded. The investigators hypothesize that nCLE can accurately distinguish malignant from benign PPLs in real time.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * (1) Age 18 years or older. (2) A peripheral pulmonary lesion identified on chest CT. (3) Bronchoscopic biopsy considered clinically necessary by the treating physician to establish a pathologic diagnosis. (4) Willingness to undergo r-EBUS and nCLE examinations. (5) Voluntary participation with written informed consent. Exclusion Criteria: * (1) A contraindication to bronchoscopy, including severe cardiopulmonary disease, coagulation disorder, failure to discontinue anticoagulant therapy or anticoagulant medication for at least 5 days before the procedure, poor tolerance of anesthesia, psychiatric illness, or severe neurosis. (2) Pregnancy or breastfeeding. (3) Known allergy to fluorescein sodium. (4) Coagulation disorder. (5) A known allergic disorder, history of asthma, hepatic failure, renal failure, or another contraindication to fluorescein sodium injection. (6) Continued use of a systemic beta-blocker on the day of the procedure, or inability to discontinue the beta-blocker safely as assessed by the investigator and anesthesiologist. (7) Inability to cooperate with the study for any reason, or any other condition that the investigator considers unsuitable for enrollment.

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Anhui Chest Hospital Hefei Hefei
The First Affiliated Hospital of Ningbo University Zhejiang Ningbo
Shanghai Chest Hospital Shanghai Shanghai Municipality

More First Affiliated Hospital of Ningbo University trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07827326 on ClinicalTrials.gov ↗ ← All trials in China